Clinical Trial Update: Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on HEC121120 examining tolerance in healthy subjects and adults with chronic hepatitis B, along with pharmacokinetics and antiviral acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HEC121120

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Hepatitis B, Chronic | Phase 1, Phase 2 | Status: TERMINATED